Biogen Inc. company logo
Biogen Inc. logo

Biogen Inc. (BIIB) Selling, General & Administrative Expenses

Annual SG&A

$2.40B$146.00M-5.73%

Summary

Current Value
As of today, BIIB annual SG&A is $2.40B, down -5.73% on
Historical Performance
BIIB annual SG&A is down -10.12% over the past 3 years, and up +1.22% over the past 5 years
All-Time High Comparison
BIIB annual SG&A is currently -10.12% below its historical high of $2.67B set on
3-Year Low Comparison
BIIB annual SG&A is at its 3-year low
Sector Comparison
BIIB annual SG&A is higher than 98.39% of companies in Healthcare sector

SG&A Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

BIIB Performance
MetricDateValue1Y3Y5Y15Y
Annual SG&A$2.40B-5.7%-10.1%+1.2%+113.3%
Quarterly SG&A$594.80M+1.1%+5.6%+3.8%+143.6%
TTM SG&A$79.50B+3308.7%+3006.9%+3263.9%+7875.5%
Price$172.62+22.4%-39.6%-36.1%+158.5%
Annual Operating Expenses$5.15B-5.9%-15.1%-4.5%+90.6%
Annual Operating Profit$2.22B+21.2%-21.0%-68.5%+71.3%
Annual D&A$673.20M+36.0%+38.0%+57.3%
Annual Revenue$9.27B-1.6%-10.9%+153.6%

SG&A Highs

BIIB Annual SG&A Highs Comparison
PeriodHighDateCurrent
3Y$2.55B-5.7%
5Y$2.67B-10.1%
All$2.67B-10.1%

SG&A Lows

BIIB Annual SG&A Lows Comparison
PeriodLowDateCurrent
3Y$2.40BN/Aat low
5Y$2.40Bat low
All$8.00M>+9999.0%

SG&A History

YearValueChange
$2.40B-5.7%
$2.55B+6.1%
$2.40B-10.1%
$2.67B+6.8%
$2.50B+5.5%
$2.37B+12.7%
$2.11B+8.9%
$1.93B-0.7%
$1.95B-7.9%
$2.11B-5.3%
$2.23B+30.4%
$1.71B+34.0%
$1.28B+21.0%
$1.06B+2.4%
$1.03B-8.5%
$1.13B+6.2%
$1.06B+36.8%
$776.10M+13.3%
$685.07M+6.3%
$644.76M+11.1%
$580.28M+232.4%
YearValueChange
$174.60M+98.4%
$88.02M-61.9%
$231.05M+36.5%
$169.27M+15.9%
$146.03M+26.7%
$115.21M+27.9%
$90.10M+22.4%
$73.63M+82.7%
$40.29M+63.2%
$24.69M-75.9%
$102.50M+19.5%
$85.80M+500.0%
$14.30M+41.6%
$10.10M+12.2%
$9.00M+8.4%
$8.30M+3.8%
$8.00M-1.2%
$8.10M-79.2%
$39.00M+381.5%
$8.10M-

FAQ

  • What is the current annual SG&A of BIIB?

    As of today, BIIB annual SG&A is $2.40B

  • What is 1-year change in BIIB annual SG&A?

    BIIB annual SG&A is down -5.73% year-over-year

  • What is 3-year change in BIIB annual SG&A?

    BIIB annual SG&A is down -10.12% over the past 3 years

  • How far is BIIB annual SG&A from its all-time high?

    BIIB annual SG&A is currently -10.12% below its historical high of $2.67B set on December 31, 2021

  • How does BIIB annual SG&A rank versus sector peers?

    BIIB annual SG&A is higher than 98.39% of companies in Healthcare sector

  • When is BIIB next annual earnings release?

    The next annual earnings release for BIIB is on

Selling, General & Administrative Expenses Formula

SG&A = − R&D

Data Sources & References

  1. BIIB Official Website www.biogen.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/875045/000087504525000049/0000875045-25-000049-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/875045/000087504525000009/0000875045-25-000009-index.htm
  4. BIIB Profile on Yahoo Finance finance.yahoo.com/quote/BIIB
  5. BIIB Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/biib